Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, ottobre 01
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Oncolytics Biotech Inc
ONCY
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.6682
-0.0063
-0.93%
Ult. Agg.: Oct 1, 5:30 AM
$0.6682
-0.0063
-0.93%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Privacy Manager
Oncolytics Biotech Financials
Oncolytics Biotech (ONCY) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Oncolytics Biotech Q2 EPS $(0.05) Beats $(0.10) Estimate
Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) by 50.5 percent. This is a 28.57 percent increase over losses of $(0.07) per share from
Benzinga Newsdesk
Earnings Scheduled For August 8, 2025
Benzinga Insights
What to Expect from Oncolytics Biotech's Earnings
Benzinga Insights
PRO
Oncolytics Biotech Q1 EPS $(0.06) Beats $(0.09) Estimate
Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 14.29 percent increase over losses of $(0.07) per share
Benzinga Newsdesk
Earnings Scheduled For May 14, 2025
Benzinga Insights
A Look at Oncolytics Biotech's Upcoming Earnings Report
Benzinga Insights
